Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2016
The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate CancerRichard J Rebello, Eric Kusnadi, Donald P Cameron, et al.Nature Communications|April 5, 2016
mTORC1 and CK2 coordinate ternary and eIF4F complex assemblyValentina Gandin, Laia Masvidal, Marie Cargnello, et al.Cancer Cell|November 3, 2009
p53-dependent translational control of senescence and transformation via 4E-BPsEmmanuel Petroulakis, Armen Parsyan, Ryan J O Dowling, et al.Oncotarget|August 28, 2019
V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN lossAmro H Mohammad, Sarah Assadian, Frédéric Couture, et al.Cancers|April 3, 2021
Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor MicroenvironmentLinda K H Teng, Brooke A Pereira, Shivakumar Keerthikumar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2024
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&TJames P Buteau, Louise Kostos, Ramin Alipour, et al.Cancer Research|January 15, 2011
Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastasesBruce W Konicek, Jennifer R Stephens, Ann M McNulty, et al.Molecular Cancer Therapeutics|August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP InhibitionMitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.Nature Immunology|May 1, 2012
Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4EBarbara Herdy, Maritza Jaramillo, Yuri V Svitkin, et al.Cancer Discovery|March 28, 2018
Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant GrowthHelen B Pearson, Jason Li, Valerie S Meniel, et al.Pageof 5